Q&A: Key Things Pharmacists Need to Know About Insulin Icodec
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses a recent meta-analysis that evaluated the efficacy, safety, and clinical implications of insulin icodec.
Trusting COVID-19 Vaccine Science Crucial in Vaccine Acceptance Among US Adults
A recent study found that losing a family member or a friend to COVID-19 within the past year led to higher levels of vaccine acceptance.
Drug Shortages More Likely in US Than in Canada
Researchers compared the issue of drug shortages and supply chain challenges between the US and Canada.
NCPA 2024 Meeting Recap
Checkout some of the most important sessions and video interviews from the 2024 National Community Pharmacists Association (NCPA) Annual Convention and Expo.
Why Vaccination Uptake is Crucial During the Winter Season
Ruth Carrico, PhD, DNP, APRN, sat down with Drug Topics to discuss the importance of COVID-19 and influenza vaccination.
Two Independent Pharmacies Latest to Sue Major PBMs
A collection of independent pharmacies was the next in line to file suits against major pharmacy benefit managers for alleged drug price fixing.
FDA Approves Journey Medical’s Emrosi for Rosacea
“Emrosi has potential to become the best-in-class oral medication to treat the condition,” said the CEO of Journey Medical.
Q&A: Understanding the Cause of Declining Vaccination Rates Amidst Flu Season
Ruth Carrico, PhD, DNP, APRN, discussed declining influenza and COVID-19 vaccination rates and how it has created a looming threat for public health officials.
FDA Expands OA REMS, Mandates Mail-Back Envelopes for Opioid Analgesics
The FDA has mandated that companies participating in the Opioid Analgesic Risk Evaluation and Mitigation Strategy program provide pre-paid mail-back envelopes for unused or expired opioid medications.
Q&A: The Importance of Vaccine Literacy, Uptake During Flu Season
Ruth Carrico, PhD, DNP, APRN, discussed the importance of annual vaccination and overall health awareness and literacy during the winter flu season.
Weekend ICYMI: October 28 to November 1
In case you missed it, this week we had stories about PBMs' threat to independent pharmacies, the risks and benefits of AI in pharmacy, pharmacists' role in hormonal prescribing, and more.
Infliximab Monotherapy Effective as Combo Therapy for Treating Inflammatory Bowel Disease
Researchers from Celltrion USA presented their post hoc analysis from the LIBERTY studies at the American College of Gastroenterology 2024 Annual Scientific Meeting.
Weekly Semaglutide Injection Reduces Knee Osteoarthritis Pain
In a recent clinical trial, weekly semaglutide demonstrated promise as a nonsurgical, nonopioid intervention for reducing knee osteoarthritis pain.
FDA Roundup: Agency Highlights from October 2024
Check out these important FDA updates from the month of October 2024.
How to Turn Patient Visits into Clinical Encounters in the Pharmacy | NCPA 2024
Presenters at the National Community Pharmacists Association 2024 Annual Convention and Expo discussed workflow and the future of pharmacy as a patient destination.
Ketamine Improved Chronic Pain for Patients with Cancer Following Surgery
Researchers conducted a systematic review of randomized trials to determine the efficacy of ketamine for patients with cancer.
Weathering the Storm: Medication Preparedness in Hurricane Season
Hurricane season brings extreme weather and health care disruptions, emphasizing the importance of medication preparedness for patients and pharmacists.
GoodRx, Opill Partner on OTC Delivery Program to Address Gaps in Access
GoodRx’s new e-commerce service further expands access to Opill by allowing consumers to order the birth control directly to their homes without a prescription.
Patient Engagement and the Future of Community Pharmacy as a Health Care Destination
Ian Stone, Senior Vice President at Mesmerize, discussed the essential aspects of a community pharmacy and how his company can help independent owners excel in the future.
The Essential Tech Stack for Pharmacy Owners
Lisa Faast, PharmD, Founder and CEO of Diversify Rx, discussed how technology is used to innovate within the pharmacy.
Women with Delayed Menopause May Face Increased Risk of Asthma
Women experiencing later menopause may face a heightened risk of asthma, underscoring the possible role of estrogen in the development of the condition.
Risk of Parkinson Disease Increases With Gastrointestinal Mucosal Damage
Researchers addressed the gut-first hypothesis of Parkinson disease by identifying how mucosal damage impacts risk of development.
Navigating the Future: Key Technology Updates Every Community Pharmacist Should Know for 2024
Timothy Aungst, PharmD, Founder of The Digital Apothecary, discussed advancements in digital health and what to be aware of regarding the future of technology.
Leveraging US Prescription Market Insights to Drive Pharmacy Innovation
Scott Biggs, Director of Supplier Services at IQVIA, discussed pharmacy trends within the industry and how pharmacists can stay ahead of them.
Guselkumab’s Promising Results as First Subcutaneous IL-23 Inhibitor to Treat Crohn’s
Johnson & Johnson announced results from its phase 3 GRAVITI trial exploring guselkumab’s results in subcutaneous (SC) induction and maintenance therapy for treating Crohn’s disease.
How Participating in Pharma-Sponsored Programs Can Benefit Your Pharmacy
A.J. Lipka, Business Development Lead of Network Growth at Outcomes, discussed the impact of pharmacy-sponsored programming.
FDA Approves Abuse-Deterrent 10 mg Oxycodone Hydrochloride for Severe Pain
The addition of a 10 mg oxycodone hydrochloride tablet improves dosing flexibility and precision.
Advancements Needed in Treating, Identifying Drug-Induced Liver Injury
Researchers analyzed the lack of prevention and treatment options for managing drug-induced liver injury.
Hormonal Contraceptive Prescribing Benefits Patients, Pharmacies | NCPA 2024
With nearly 7 million women living in a health care desert, pharmacists can provide crucial reproductive care services.
Mid-Meeting Recap | NCPA 2024
The NCPA 2024 Annual Convention and Expo runs through October 29, 2024, in Columbus, Ohio.